|
Volumn 60, Issue 2, 2012, Pages
|
Serum potassium, thiazides, aldosterone, and mineralocorticoid receptors
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALDOSTERONE;
AMLODIPINE;
CANRENONE;
CHLORTALIDONE;
EPLERENONE;
HYDROCHLOROTHIAZIDE;
LISINOPRIL;
MINERALOCORTICOID RECEPTOR;
PLASMINOGEN ACTIVATOR INHIBITOR 1;
POTASSIUM;
SPIRONOLACTONE;
THIAZIDE DIURETIC AGENT;
ACUTE HEART INFARCTION;
ALDOSTERONE BLOOD LEVEL;
ANTIHYPERTENSIVE THERAPY;
CARDIOVASCULAR RISK;
CONGESTIVE HEART FAILURE;
DISEASE SEVERITY;
HEART FAILURE;
HEART HYPERTROPHY;
HEART MUSCLE FIBROSIS;
HUMAN;
HYPERKALEMIA;
HYPOKALEMIA;
IN VITRO STUDY;
LETTER;
LOW DRUG DOSE;
LYMPHOCYTE;
POTASSIUM BLOOD LEVEL;
PRIORITY JOURNAL;
RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;
RISK REDUCTION;
SURVIVAL;
ANTIHYPERTENSIVE AGENTS;
FEMALE;
HUMANS;
HYPERKALEMIA;
HYPERTENSION;
HYPOKALEMIA;
MALE;
MYOCARDIAL INFARCTION;
|
EID: 84864289654
PISSN: 0194911X
EISSN: 15244563
Source Type: Journal
DOI: 10.1161/HYPERTENSIONAHA.112.197889 Document Type: Letter |
Times cited : (4)
|
References (5)
|